CEFALY Publishes the First and Largest, Phase 3 Clinical Trial of 2-hour External Trigeminal Nerve Stimulation (e-TNS) for At-Home Acute Migraine Treatment
/PRNewswire/ -- CEFALY Technology, a Belgium-based manufacturer of wearable medical devices for migraine, today announced the results of a clinical study...
United States Jen Trainor Mcdermott Deena Kuruvilla Cefaly Technology Westport Headache Institute Health Organization
Source: prnewswire.com